Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Mangalam Drugs and Organics Ltd

NSE: MANGALAM · BSE: 532637 · Pharmaceuticals & Biotechnology · 33 announcements

Share price
₹33.09
Market cap
₹52.38 Cr
Revenue (annual)
₹232.1 Cr
Net profit (annual)
₹-44.40 Cr
P/E (TTM)
-1.4×Sector 47.3×
Promoter holding
35.65%+0.00% QoQ
FII holding
0.11%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:35 IST NSE
Debt & Borrowing

Mangalam Drugs and Organics Debt & Borrowing: ₹15.57 Cr

Mangalam Drugs disclosed a default on loan obligations to Bank of Maharashtra and Bank of Baroda, totaling ₹15.57 Crore in overdue amounts.

Value
₹15.57 Cr
16:39 IST BSE
Debt & Borrowing

Mangalam Drugs and Organics Debt & Borrowing: ₹15.57 Cr

Mangalam Drugs disclosed defaults on loan obligations to Bank of Baroda and Bank of Maharashtra, totaling ₹15.57 Crore in overdue amounts.

Value
₹15.57 Cr
18:04 IST BSE
Debt & Borrowing

Mangalam Drugs and Organics Debt & Borrowing: ₹15.57 Cr

Mangalam Drugs and Organics reported a Rs. 15.57 Crore default on cash credit facilities. The defaults involve Bank of Baroda and Bank of Maharashtra accounts.

Value
₹15.57 Cr
17:40 IST BSE
Debt & Borrowing

Mangalam Drugs and Organics Debt & Borrowing: ₹15.57 Cr

Mangalam Drugs and Organics reported a Rs 15.57 Crore default on cash credit facilities from two banks. The company is arranging funds to clear the overdue amounts.

Value
₹15.57 Cr
22:29 IST NSE
Debt & Borrowing

Mangalam Drugs and Organics Debt & Borrowing: ₹50.19 Cr

Mangalam Worldwide submitted a security cover certificate for Rs. 50.19 Crore NCDs. The market value security cover ratio is 1.27.

Value
₹50.19 Cr